PRJNA375882: Comprehensive Mouse Transcriptomic BodyMap
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Tal1 | mm39_v1_chr4_+_114916703_114916759 | 0.81 | 4.0e-18 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr15_-_103159892 Show fit | 29.64 |
ENSMUST00000133600.8
ENSMUST00000134554.2 ENSMUST00000156927.8 |
nuclear factor, erythroid derived 2 |
|
chr15_-_103160082 Show fit | 24.72 |
ENSMUST00000149111.8
ENSMUST00000132836.8 |
nuclear factor, erythroid derived 2 |
|
chr4_+_132701413 Show fit | 21.84 |
ENSMUST00000030693.13
|
FGR proto-oncogene, Src family tyrosine kinase |
|
chr17_+_41121979 Show fit | 21.08 |
ENSMUST00000024721.8
ENSMUST00000233740.2 |
Rhesus blood group-associated A glycoprotein |
|
chr17_+_37180437 Show fit | 18.84 |
ENSMUST00000060524.11
|
tripartite motif-containing 10 |
|
chr1_+_131566044 Show fit | 16.79 |
ENSMUST00000073350.13
|
cathepsin E |
|
chr8_+_81220410 Show fit | 16.42 |
ENSMUST00000063359.8
|
glycophorin A |
|
chr1_+_131566223 Show fit | 16.27 |
ENSMUST00000112411.2
|
cathepsin E |
|
chr1_+_174000304 Show fit | 15.73 |
ENSMUST00000027817.8
|
spectrin alpha, erythrocytic 1 |
|
chr5_+_90920294 Show fit | 15.55 |
ENSMUST00000031320.8
|
platelet factor 4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.6 | 54.4 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
8.5 | 34.0 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
1.7 | 33.1 | GO:0016540 | protein autoprocessing(GO:0016540) |
6.1 | 30.4 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.2 | 21.8 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.8 | 21.8 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.9 | 20.4 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
0.8 | 19.3 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.5 | 19.1 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
1.5 | 17.5 | GO:0001955 | blood vessel maturation(GO:0001955) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 104.6 | GO:0005615 | extracellular space(GO:0005615) |
0.3 | 57.7 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 57.1 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 53.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
2.6 | 36.8 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.0 | 28.8 | GO:0005768 | endosome(GO:0005768) |
0.4 | 21.8 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 18.1 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 17.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
2.2 | 15.7 | GO:0032437 | cuticular plate(GO:0032437) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 62.2 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.9 | 54.4 | GO:0050699 | WW domain binding(GO:0050699) |
1.0 | 35.0 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
1.0 | 32.4 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
5.1 | 30.4 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
1.3 | 26.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
3.6 | 21.8 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.0 | 19.9 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.1 | 17.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 15.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 32.8 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.5 | 25.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 24.2 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.6 | 11.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.3 | 10.6 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 9.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 9.1 | PID EPO PATHWAY | EPO signaling pathway |
0.2 | 7.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.5 | 7.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 6.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 49.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.5 | 37.0 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
1.8 | 30.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.6 | 21.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.4 | 21.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.5 | 20.7 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.3 | 18.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 12.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.6 | 9.6 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 9.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |